Laboratory Corp. of America Holdings plans to spin off its unit focused on clinical drug trials, a move that will create a new stand-alone company in the fast-growing contract-research sector.

Burlington, N.C.-based Labcorp unveiled the plan to separate its clinical-development business Thursday alongside its second-quarter results. Labcorp will continue its focus on its core diagnostic-testing business and will also retain two related pieces of its drug-development unit.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Mickey Gilley, country star who helped inspire ‘Urban Cowboy,’ dies at 86

NEW YORK — Country star Mickey Gilley, whose namesake Texas honky-tonk inspired…

‘I should believe more in myself’: Naomi Osaka returns with first round win at U.S. Open

Here’s the realization Naomi Osaka came to, gradually and only recently: If…

Blinken Warns Against Fake Exit by Russia in Ukraine War

This post first appeared on wsj.com

Parts of Australia’s Great Barrier Reef show highest coral cover in 36 years

The report comes as UNESCO considers whether to list the Great Barrier…